Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

October 15, 2020

Prime Time For..."Protected TAVI"

Presentation JIM 2018

Prime Time For..."Protected TAVI"

Presenter: Martin B. Leon

February 23, 2018

TCTMD’s Top 10 Most Popular Stories for June 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

July 03, 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

June 12, 2017

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

Presentation TVT 2014

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

Presenter: Martin B. Leon

June 07, 2014

Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function

Presentation TVT 2013

Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function

Presenter: Martin Leon

June 12, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.